NBIX vs VSEC · P/E 45, rev $1.77B vs P/E 54, rev $773.7M
Neurocrine Biosciences Inc (NBIX) versus VSE Corporation (VSEC) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
VSE Corporation (VSEC) is a aerospace & defense company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported VSEC revenue for 2026-06-30 was $773.7M. Net income was $57.6M. VSEC currently screens at market cap $2.65B and trailing P/E 54.5.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. VSEC currently screens at market cap $2.65B and trailing P/E 54.5.
Not investment advice. Open the NBIX and VSEC stock pages for the full models.
Not investment advice.